Diagnostic tests in neonatal sepsis

Current Opinion in Infectious Diseases

Volumn 21, Issue 3, 2008, Pages 223-227

  Arnon, Shmuel ^a,b   Litmanovitz, Ita ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute phase reactant; Cell surface antigens; Cytokines; Neonatal sepsis; Polymerase chain reaction

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CD11B ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; CD69 ANTIGEN; FIBRONECTIN; GRANULOCYTE COLONY STIMULATING FACTOR; HAPTOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; LACTOFERRIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; NEOPTERIN; PROCALCITONIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ACCURACY; BACTERIAL GENOME; BLOOD CELL COUNT; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC TEST; HUMAN; NEWBORN SEPSIS; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PROTEOMICS; REVIEW; VERY LOW BIRTH WEIGHT;

ACUTE-PHASE PROTEINS; AMNIOTIC FLUID; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CYTOKINES; HUMANS; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; PROTEOMICS; SEPSIS;

EID: 42949124438     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282fa15dd     Document Type: Review

References (49)

1. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51:939-959.
2. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003; 29:1043-1051.
3. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 2006; 18:125-131.
4. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006; 91:F208-F212.
5. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998; 17:593-598.
6. Okascharoen C, Hui C, Cairnie J, et al. External validation of bedside prediction score for diagnosis of late-onset neonatal sepsis. J Perinatol 2007; 27:496-501.
7. Kudawla M, Dutta S, Narang A. Validation of a clinical score for the diagnosis of late onset neonatal septicemia in babies weighing 1000 2500 g. J Trop Pediatr 2008; 54:66-69.
8. Schelonka RL, Yoder BA, Hall RB, et al. Differentiation of segmented and band neutrophils during the early newborn period. J Pediatr 1995; 127:298-300.
9. Verboon-Maciolek MA, Thijsen SF, Hemels MA, et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 2006; 59:457-461.
10. Turner D, Hammerman C, Rudensky B, et al. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr 2006; 95:1571-1576.
11. López Sastre JB, Pérez Solís D, Roqués Serradilla V, et al. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatrics 2006; 6:16.
12. Arnon S, Litmanovitz I, Regev RH, et al. Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis. J Perinatol 2007; 27:297-302.
13. Arnon S, Litmanovitz I, Regev R, et al. Serum amyloid A protein in the early detection of late-onset bacterial sepsis in preterm infants. J Perinat Med 2002; 30:329-332.
14. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 2007; 33:1025-1032.
15. Ng PC, Li G, Chui KM, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 2004; 56:796-803.
16. Ng PC, Li K, Wong RP, et al. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birth weight infants. Pediatr Res 2002; 51:296-303.
17. Orlikowsky TW, Neunhoeffer F, Goelz R, et al. Evaluation of IL-8-concentrations in plasma and lysed EDTA blood in healthy neonates and those with suspected early onset bacterial infection. Pediatr Res 2004; 56:804-809.
18. Franz AR, Bauer K, Schalk A, et al. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics 2004; 114:1-8.
19. Shang S, Chen G, Wu Y, et al. Rapid diagnosis of bacterial sepsis with PCR amplification and microarray hybridization in 16S rRNA gene. Pediatr Res 2005; 58:143-148.
20. Griffin MP, Lake DE, Moorman JR. Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics 2005; 115:937-941.
21. Griffin MP, Lake DE, O'Shea TM, Moorman JR. Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res 2007; 61:222-227. The study examines the relationship between HRC index and a clinical score in neonatal sepsis and points out that the former is adjunctive and not a substitute for clinical information.
22. Moorman JR, Lake DE, Griffin MP. Heart rate characteristics monitoring for neonatal sepsis. IEEE Trans Biomed Eng 2006; 53:126-132.
23. Goldstein B. Heart rate characteristics in neonatal sepsis: a promising test that is still premature. Pediatrics 2005; 115:1070-1072; Comment on Pediatrics. 2005; 115:937-941..
24. Bataineh HA, Alrashed KM. C-reactive protein in Neonates with suspected septicemia. Rawal Med J 2007; 32:25-27.
25. Couto RC, Barbosa JA, Pedrosa TM, Biscione FM. C-reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis: an intervention study. Braz J Infect Dis 2007; 11:240-245.
26. Franz AR, Kron M, Pohlandt F, Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J 1999; 18:666-671.
27. Haque KN. Defining common infections in children and neonates. J Hosp Infect 2007; 65 (Suppl 2):110-114.
28. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007; 7:210-217.
29. Kocabaş E, Sarkçoǧ lu A, Aksaray N, et al. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-α in the diagnosis of neonatal sepsis. Turk J Pediatr 2007; 49:7-20.
30. Turner D, Hammerman C, Rudensky B, et al. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 2006; 91:F283-F286.
31. Llorente E, Prieto B, Cardo L, et al. Umbilical cord blood serum procalcitonin by time-resolved amplified cryptate emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis. Clin Chem Lab Med 2007; 45:1531-1535.
32. Golden SM, Hague I, Elwood R, et al. Serum amyloid A concentrations in full-term infant umbilical cord serum using a solid phase indirect ELISA. Lab Med 2005; 36:357-360.
33. Zweigner J, Schumann RR, Weber JR. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microb Infect 2006; 8:946-952.
34. Ersoy B, Nehir H, Altinoz S, et al. Prognostic value of initial antithrombin levels in neonatal sepsis. Indian Pediatr 2007; 44:581-584.
35. Hodge G, Hodge S, Han P, Haslam R. Multiple leucocyte activation markers to detect neonatal infection. Clin Exp Immunol 2004; 135:125-129.
36. Gille C, Orlikowsky TW. Flow cytometric methods in the detection of neonatal infection. Transfus Med Hemother 2007; 34:157-163. Summarizing the different flow cytometric markers to detect neonatal sepsis and their clinical and laboratory characteristics, the study stresses the role of cell surface antigens to stop antibiotics when the child is healthy and the lack of accuracy of these markers to withhold antibiotics when the child is sick and suspected of having sepsis.
37. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88:F209-F213.
38. Horisberger T, Harbarth S, Nadal D, et al. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial. Crit Care 2004; 8:R443-R450.
39. Ng PC, Li K, Leung TF, et al. Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006; 52:1181-1189.
40. Ng PC, Li K, Chui KM, et al. IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res 2007; 61:93-98. A well designed study showing that preterm infants have the ability to induce a robust chemokine and cytokine response during sepsis, with IP-10 being a sensitive early marker of infection.
41. Bentlin MR, de Souza Rugolo LM, Júnior AR, et al. Is urine interleukin-8 level a reliable laboratory test for diagnosing late onset sepsis in premature infants? J Trop Pediatr 2007; 53:403-408.
42. Jordan JA, Durso MB, Butchko AR, et al. Evaluating the near-term infant for early onset sepsis. Progress and challenges to consider with 16S rDNA polymerase chain reaction testing. J Mol Diagn 2006; 8:357-363.
43. Jordan JA, Durso MB. Real-time polymerase chain reaction for detecting bacterial DNA directly from blood of neonates being evaluated for sepsis. J Mol Diagn 2005; 7:575-581.
44. Makhoul IR, Yacoub A, Smolkin T, et al. Values of C-reactive protein, procalcitonin, and Staphylococcus-specific PCR in neonatal late-onset sepsis. Acta Paediatr 2006; 95:1218-1223.
45. Makhoul IR, Smolkin T, Sujov P, et al. PCR-based detection of neonatal Staphylococca bacteremias. J Clin Microbiol 2005; 43:4823-4825.
46. Brozanski BS, Jones JG, Krohn MJ, Jordan JA. Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay. J Perinatol 2006; 26:688-692.
47. Buhimschi CS, Bhandari V, Hamar BD, et al. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007; 4:e18.
48. Buhimschi CS, Buhimschi IA, Abdel-Razeq S, et al. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 2007; 61:318-324. The study presents the emerging field of proteomics in the evaluation of the newborn at risk for EOS. Amniotic fluid proteomic analysis showed that high mass restricted score was strongly associated with histological funisitis and with early neonatal sepsis.
49. Buhimschi IA, Christner R, Buhimschi CS. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005; 112:173-181.